Home › Trial NCT01642017
Phase I Clinical and Pharmacokinetic Study of Pazopanib in a Population of Frail Elderly Patients According SIOG Criteria
- Trial IDNCT01642017
- StatusTerminated
- PhasePhase 1
- Study typeInterventional
- SponsorInstitut Claudius Regaud
- Enrollment18
- Start date2012-11-22
- ConditionsMetastatic Cancer (Different Solid Tumour Types)
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.